CN1748573A - Nutritious food containing astaxanthin and its preparation method - Google Patents
Nutritious food containing astaxanthin and its preparation method Download PDFInfo
- Publication number
- CN1748573A CN1748573A CNA2005101001549A CN200510100154A CN1748573A CN 1748573 A CN1748573 A CN 1748573A CN A2005101001549 A CNA2005101001549 A CN A2005101001549A CN 200510100154 A CN200510100154 A CN 200510100154A CN 1748573 A CN1748573 A CN 1748573A
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- vitamin
- yeast extract
- add
- mixing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 51
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 51
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 51
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 51
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 51
- 235000013305 food Nutrition 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 235000008935 nutritious Nutrition 0.000 title abstract description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 58
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 29
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 29
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 29
- 239000011718 vitamin C Substances 0.000 claims abstract description 29
- 239000012138 yeast extract Substances 0.000 claims abstract description 29
- 239000002775 capsule Substances 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 18
- 229920002472 Starch Polymers 0.000 claims description 14
- 235000019698 starch Nutrition 0.000 claims description 14
- 239000008107 starch Substances 0.000 claims description 14
- 229920001353 Dextrin Polymers 0.000 claims description 12
- 239000004375 Dextrin Substances 0.000 claims description 12
- 235000019425 dextrin Nutrition 0.000 claims description 12
- 238000005469 granulation Methods 0.000 claims description 8
- 230000003179 granulation Effects 0.000 claims description 8
- 235000016709 nutrition Nutrition 0.000 claims description 8
- 239000000654 additive Substances 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 230000035764 nutrition Effects 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 2
- 238000012856 packing Methods 0.000 claims 2
- 239000000470 constituent Substances 0.000 claims 1
- 229920001971 elastomer Polymers 0.000 claims 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 239000005060 rubber Substances 0.000 claims 1
- 238000012859 sterile filling Methods 0.000 claims 1
- 235000020985 whole grains Nutrition 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 description 26
- 230000036737 immune function Effects 0.000 description 14
- 230000005855 radiation Effects 0.000 description 14
- 230000003712 anti-aging effect Effects 0.000 description 13
- 239000008187 granular material Substances 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 231100000331 toxic Toxicity 0.000 description 13
- 230000002588 toxic effect Effects 0.000 description 13
- 208000024172 Cardiovascular disease Diseases 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 206010039073 rheumatoid arthritis Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000002708 enhancing effect Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 5
- 230000035790 physiological processes and functions Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 208000030533 eye disease Diseases 0.000 description 4
- 208000002177 Cataract Diseases 0.000 description 3
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- 229960004999 lycopene Drugs 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 3
- -1 vitamins Chemical compound 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 description 2
- 239000009429 Ginkgo biloba extract Substances 0.000 description 2
- 208000001456 Jet Lag Syndrome Diseases 0.000 description 2
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 description 2
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 2
- 229960003987 melatonin Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 238000012371 Aseptic Filling Methods 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及食品及其加工技术,特别是一种含虾青素营养食品及其制备方法。The invention relates to food and its processing technology, in particular to a nutritious food containing astaxanthin and a preparation method thereof.
技术背景technical background
虾青素,称为3,3′-二羟基-4,4′-二酮基-β,β′-胡萝卜素,分子式C40H52O4,分子量596.86,是一种萜烯类不饱和化合物,呈粉红色,是600多种类胡萝卜素中的一种。虾青素的结构式如下所示:Astaxanthin, known as 3,3′-dihydroxy-4,4′-diketone-β,β′-carotene, molecular formula C 40 H 52 O 4 , molecular weight 596.86, is a terpene-like unsaturated The compound, in pink, is one of more than 600 carotenoids. The structural formula of astaxanthin is as follows:
虾青素是甲壳类动物、鲑鱼、各种鸟类和水果中的主要色素,由于虾青素不是维生素A原,所以以前认为它不具备生理活性,然而近年的研究表明,虾青素具有抗氧化、抗肿瘤和增强免疫力等许多重要的生理和生物学功能,其抗氧化性能比维生素E强100-500倍,比胡萝卜素强10倍以上,动物试验表明虾青素有抗肿瘤、抗紫外辐射、增强免疫功能,是水生动物的强抗氧化剂和脂质过氧化的抑制剂;可以抑制老年斑的形成,对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用;最新研究发现,虾青素对视频显示终端操作员视觉疲劳具有明显的改善作用,还有助于消除因时差而产生的身体不适感,其效果比常用的褪黑激素还要明显。对作息时间陷於紊乱的中小学生和老人恢复正常的生活节奏也有帮助作用。所以,虾青素具有重要的营养和保健作用。但虾青素与维生素一样不能被人体合成,只能从食物中摄取。Astaxanthin is the main pigment in crustaceans, salmon, various birds and fruits. Since astaxanthin is not a provitamin A, it was previously considered to have no physiological activity. However, recent studies have shown that astaxanthin has anti-inflammatory properties. It has many important physiological and biological functions such as oxidation, anti-tumor and immunity enhancement. Its antioxidant performance is 100-500 times stronger than that of vitamin E, and more than 10 times stronger than that of carotene. Animal experiments have shown that astaxanthin has anti-tumor, anti Ultraviolet radiation, enhancing immune function, is a strong antioxidant and inhibitor of lipid peroxidation in aquatic animals; it can inhibit the formation of senile plaques, and has a relieving effect on eye diseases, cardiovascular diseases and rheumatoid arthritis; the latest research has found that, Astaxanthin can significantly improve the visual fatigue of video display terminal operators, and also help eliminate the physical discomfort caused by jet lag, and its effect is more obvious than that of commonly used melatonin. It is also helpful for primary and middle school students and the elderly whose work and rest time is in disorder to restore their normal rhythm of life. Therefore, astaxanthin has important nutritional and health functions. But astaxanthin, like vitamins, cannot be synthesized by the human body and can only be ingested from food.
发明内容Contents of the invention
本发明的目的在于提供一种含虾青素营养食品,专供人类营养和保健之需要,促进人类健康。The object of the present invention is to provide a nutritious food containing astaxanthin, which is specially for the needs of human nutrition and health care, and promotes human health.
本发明的目的还在于提供所述含虾青素营养食品的制备方法。The object of the present invention is also to provide a preparation method of the nutritional food containing astaxanthin.
本发明的含虾青素营养食品由维生素C、酵母抽提物、虾青素制成,各组分重量份数如下:The nutritional food containing astaxanthin of the present invention is made of vitamin C, yeast extract and astaxanthin, and the parts by weight of each component are as follows:
维生素C 0.01-0.5Vitamin C 0.01-0.5
酵母抽提物 0.1-5Yeast extract 0.1-5
虾青素 0.01-2。Astaxanthin 0.01-2.
本发明的含虾青素营养食品的制备方法包括如下步骤:The preparation method of the nutritional food containing astaxanthin of the present invention comprises the following steps:
(1)维生素C、酵母抽提物、虾青素及辅料混合;(1) Vitamin C, yeast extract, astaxanthin and auxiliary materials are mixed;
(2)制备成胶囊、片剂或口服液。(2) Prepared into capsules, tablets or oral liquids.
各组分的质量份数为:The mass parts of each component are:
维生素C 0.01-0.5Vitamin C 0.01-0.5
酵母抽提物 0.1-5Yeast extract 0.1-5
虾青素 0.01-2Astaxanthin 0.01-2
辅料 40-95;Accessories 40-95;
所述酵母抽提物是现有技术通用方法制备得到的公知的酵母抽提物。The yeast extract is a well-known yeast extract prepared by a common method in the prior art.
所述辅料是指为制备各种剂型如胶囊、片剂或口服液等而采用的赋形剂、为调整口味而添加的调味剂、为增加其他方面的营养而添加的其他辅料等等,可以根据需要加入。Said adjuvant refers to the excipient used to prepare various dosage forms such as capsules, tablets or oral liquids, the flavoring agent added to adjust the taste, other adjuvant added to increase other aspects of nutrition, etc., can be Join as needed.
虾青素可以由藻类、鱼、虾、蟹、酵母或其他植物中提取,或者人工合成。Astaxanthin can be extracted from algae, fish, shrimp, crab, yeast or other plants, or synthetically.
所述胶囊、片剂或口服液等剂型可以采用现有的通用方法配合赋形剂制备得到。例如制备胶囊时,采用如下工艺:维生素C和淀粉或糊精混匀→加虾青素和其他添加剂混匀→制粒→烘干→装胶囊擦胶后分装入瓶。The dosage forms such as capsules, tablets or oral liquids can be prepared by using existing general methods with excipients. For example, when preparing capsules, the following process is adopted: mixing vitamin C with starch or dextrin → adding astaxanthin and other additives and mixing → granulating → drying → filling capsules and rubbing glue, and then filling them into bottles.
制备片剂时,其工艺如下:将维生素C、酵母抽提物、淀粉浆、蔗糖混匀→加虾青素和其他添加剂混匀→制粒→干燥→整粒→压片→包装。When preparing tablets, the process is as follows: mix vitamin C, yeast extract, starch slurry, and sucrose → add astaxanthin and other additives and mix → granulate → dry → granulate → tablet → pack.
制备口服液时,其工艺如下:将维生素C、酵母抽提物、糖浆、香精混匀→加虾青素和其他添加剂混匀→加水搅拌均匀→均质→高温灭菌→无菌灌装。When preparing the oral liquid, the process is as follows: mix vitamin C, yeast extract, syrup, essence, mix evenly, add astaxanthin and other additives, mix evenly, add water and stir evenly, homogenize, high temperature sterilization, aseptic filling.
本发明与现有技术相比,具有如下优点:Compared with the prior art, the present invention has the following advantages:
1、本发明制备的营养食品具有抗氧化、抗肿瘤和增强免疫力等许多重要的生理和生物学功能,其中虾青素的抗氧化性能比维生素E强100-500倍,比胡萝卜素强10倍以上,是目前类胡萝卜素中抗氧化性能最强的色素。1. The nutritious food prepared by the present invention has many important physiological and biological functions such as anti-oxidation, anti-tumor and immunity enhancement, among which the anti-oxidation performance of astaxanthin is 100-500 times stronger than that of vitamin E, and 10 times stronger than that of carotene. It is currently the pigment with the strongest antioxidant performance among carotenoids.
2、本发明制备的营养食品还具有一些其他类胡萝卜素所不具有的功能:①抑制老年斑的形成;②对眼科疾病、心血管疾病和类风湿性关节炎有缓解作用;③对视频显示终端操作员视觉疲劳具有明显的改善作用;④有助于消除因时差而产生的身体不适感,其效果比常用的褪黑激素还要明显;⑤对作息时间陷於紊乱的中小学生和老人恢复正常的生活节奏也有帮助作用;⑥对调节肩周润滑有帮助作用。2. The nutritious food prepared by the present invention also has some functions that other carotenoids do not have: ① inhibit the formation of senile plaques; ② relieve eye diseases, cardiovascular diseases and rheumatoid arthritis; ③ treat video display terminals It can significantly improve the visual fatigue of operators; ④ helps to eliminate the physical discomfort caused by jet lag, and its effect is more obvious than that of commonly used melatonin; The rhythm of life is also helpful; ⑥It is helpful for regulating shoulder lubrication.
3、本发明制备的营养食品与DHA、番茄红素、银杏叶抽提物等功能物质调配使用,不仅能增强该营养食品的功能,而且能够强化虾青素的功能。3. The nutritious food prepared by the present invention is used in combination with functional substances such as DHA, lycopene, and ginkgo leaf extract, which can not only enhance the function of the nutritious food, but also strengthen the function of astaxanthin.
具体实施方式Detailed ways
实施例1、以生产1000粒片剂为例Embodiment 1, take the production of 1000 tablets as an example
将适量淀粉或糊精、0.05克维生素C、25克酵母抽提物混匀,加入虾青素10克混匀,制粒后烘干,整粒后压片(每片重0.5克),装瓶封盖贴标即可。Mix appropriate amount of starch or dextrin, 0.05g of vitamin C, and 25g of yeast extract, add 10g of astaxanthin, mix evenly, granulate, dry, press into tablets after granulation (each tablet weighs 0.5g), pack The bottle is capped and labeled.
服用方法:每天1粒。该产品具有抗衰老、抗紫外辐射、增强免疫功能,对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用,无毒副作用。Dosage: 1 capsule per day. The product has the functions of anti-aging, anti-ultraviolet radiation, enhancing immune function, and also has a relieving effect on eye diseases, cardiovascular diseases and rheumatoid arthritis, and has no toxic side effects.
实施例2、以生产1000粒片剂为例Embodiment 2, take the production of 1000 tablets as an example
将适量淀粉或糊精、2.5克维生素C、0.5克酵母抽提物混匀,加入虾青素0.05克混匀,制粒后烘干,整粒后压片(每片重0.5克),装瓶封盖贴标即可。Mix an appropriate amount of starch or dextrin, 2.5 grams of vitamin C, and 0.5 grams of yeast extract, add 0.05 grams of astaxanthin and mix them evenly, dry them after granulation, compress the granules (each tablet weighs 0.5 grams), pack The bottle is capped and labeled.
服用方法同实施例1,该产品具有抗衰老、抗紫外辐射、增强免疫功能,对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用,无毒副作用。The taking method is the same as that in Example 1. The product has the functions of anti-aging, anti-ultraviolet radiation, enhancing immune function, and also has a relieving effect on ophthalmic diseases, cardiovascular diseases and rheumatoid arthritis, and has no toxic and side effects.
实施例3、以生产1000粒片剂为例Embodiment 3, take the production of 1000 tablets as an example
将适量淀粉或糊精、1.0克维生素C、1.5克酵母抽提物混匀,加入虾青素2克混匀,制粒后烘干,整粒后压片(每片重0.5克),装瓶封盖贴标即可。Mix an appropriate amount of starch or dextrin, 1.0 g of vitamin C, and 1.5 g of yeast extract, add 2 g of astaxanthin, mix evenly, granulate, dry, and press into tablets after granulation (each tablet weighs 0.5 g). The bottle is capped and labeled.
服用方法同实施例1,该产品具有抗衰老、抗紫外辐射、增强免疫功能,对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用,无毒副作用。The taking method is the same as that in Example 1. The product has the functions of anti-aging, anti-ultraviolet radiation, enhancing immune function, and also has a relieving effect on ophthalmic diseases, cardiovascular diseases and rheumatoid arthritis, and has no toxic and side effects.
实施例4、以生产1000粒胶囊为例Embodiment 4, take the production of 1000 capsules as an example
将适量淀粉或糊精、0.05克维生素C、25克酵母抽提物混匀,加入虾青素10克混匀,制粒后烘干,装胶囊(每粒重0.5克左右),擦胶后分装入瓶即可。Mix an appropriate amount of starch or dextrin, 0.05 grams of vitamin C, and 25 grams of yeast extract, add 10 grams of astaxanthin and mix evenly, granulate and dry, put in capsules (each weighing about 0.5 grams), and rub the glue Divide into bottles.
服用方法同实施例1,该产品具有抗衰老、抗紫外辐射、增强免疫功能,对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用,无毒副作用。The taking method is the same as that in Example 1. The product has the functions of anti-aging, anti-ultraviolet radiation, enhancing immune function, and also has a relieving effect on ophthalmic diseases, cardiovascular diseases and rheumatoid arthritis, and has no toxic and side effects.
实施例5、以生产1000粒胶囊为例Embodiment 5, take the production of 1000 capsules as an example
将适量淀粉或糊精、2.5克维生素C、0.5克酵母抽提物混匀,加入虾青素0.05克混匀,制粒后烘干,装胶囊(每粒重0.5克左右),擦胶后分装入瓶即可。Mix an appropriate amount of starch or dextrin, 2.5 grams of vitamin C, and 0.5 grams of yeast extract, add 0.05 grams of astaxanthin, mix well, granulate and dry, pack into capsules (each weighing about 0.5 grams), and rub the glue Divide into bottles.
服用方法同实施例1,该产品具有抗衰老、抗紫外辐射、增强免疫功能,对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用,无毒副作用。The taking method is the same as that in Example 1. The product has the functions of anti-aging, anti-ultraviolet radiation, enhancing immune function, and also has a relieving effect on ophthalmic diseases, cardiovascular diseases and rheumatoid arthritis, and has no toxic and side effects.
实施例6、以生产1000粒胶囊为例Embodiment 6, take the production of 1000 capsules as an example
将淀粉或糊精、1.0克维生素C、1.5克酵母抽提物混匀,加入虾青素2克混匀,制粒后烘干,装胶囊(每粒重0.5克左右),擦胶后分装入瓶即可。Mix starch or dextrin, 1.0 g of vitamin C, and 1.5 g of yeast extract, add 2 g of astaxanthin, mix evenly, granulate, dry, put in capsules (each weighing about 0.5 g), and divide after rubbing Just bottle it.
服用方法同实施例1,证明该产品具有抗衰老、抗紫外辐射、增强免疫功能,对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用,无毒副作用。The administration method is the same as that in Example 1, which proves that the product has anti-aging, anti-ultraviolet radiation, enhanced immune function, and also has a relieving effect on eye diseases, cardiovascular diseases and rheumatoid arthritis, and has no toxic and side effects.
实施例7、以生产1000支口服液为例Embodiment 7, take the production of 1000 oral liquids as an example
将1.0克维生素C、500克酵母抽提物混匀,加入虾青素200克,蔗糖800克混匀,加水至10000毫升搅拌混匀,均质后经高温灭菌灌装。Mix 1.0 g of vitamin C and 500 g of yeast extract, add 200 g of astaxanthin, and 800 g of sucrose, mix evenly, add water to 10,000 ml, mix evenly, and after homogenization, sterilize and fill at high temperature.
服用方法:每天1支。证明该产品具有抗衰老、抗紫外辐射、增强免疫功能,对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用,无毒副作用。Dosage: 1 stick per day. It has been proved that the product has anti-aging, anti-ultraviolet radiation, enhanced immune function, and also has a relieving effect on ophthalmic diseases, cardiovascular diseases and rheumatoid arthritis, and has no toxic and side effects.
实施例8、以生产1000支口服液为例Embodiment 8, take the production of 1000 oral liquids as an example
将50克维生素C、10克酵母抽提物混匀,加入虾青素1克,蔗糖600克混匀,加水至10000毫升搅拌混匀,均质后经高温灭菌灌装。Mix 50 grams of vitamin C and 10 grams of yeast extract, add 1 gram of astaxanthin, 600 grams of sucrose and mix, add water to 10000 ml, stir and mix, homogenize, and then sterilize and fill at high temperature.
服用方法同实施例7,该产品具有抗衰老、抗紫外辐射、增强免疫功能,对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用,无毒副作用。The taking method is the same as that in Example 7. The product has anti-aging, anti-ultraviolet radiation, enhanced immune function, and also has a relieving effect on ophthalmic diseases, cardiovascular diseases and rheumatoid arthritis, and has no toxic and side effects.
实施例9、以生产1000支口服液为例Embodiment 9, taking the production of 1000 oral liquids as an example
将25克维生素C、200克酵母抽提物混匀,加入虾青素100克,蔗糖800克混匀,加水至10000毫升搅拌混匀,均质后经高温灭菌灌装。Mix 25 grams of vitamin C and 200 grams of yeast extract, add 100 grams of astaxanthin, and 800 grams of sucrose, mix well, add water to 10,000 ml, stir and mix well, after homogenization, sterilize and fill at high temperature.
服用方法同实施例7,该产品具有抗衰老、抗紫外辐射、增强免疫功能,对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用,无毒副作用。The taking method is the same as that in Example 7. The product has anti-aging, anti-ultraviolet radiation, enhanced immune function, and also has a relieving effect on ophthalmic diseases, cardiovascular diseases and rheumatoid arthritis, and has no toxic and side effects.
实施例10、以生产1000粒片剂为例Embodiment 10, take the production of 1000 tablets as an example
将适量淀粉或糊精、1.0克维生素C、1.5克酵母抽提物混匀,加入DHA原液100克(内含DHA约为25%)和虾青素2克混匀,制粒后烘干,整粒后压片(每片重0.5克),装瓶封盖贴标即可。Mix an appropriate amount of starch or dextrin, 1.0 g of vitamin C, and 1.5 g of yeast extract, add 100 g of DHA stock solution (containing about 25% DHA) and 2 g of astaxanthin, mix evenly, granulate and dry, Tablets (each tablet weighs 0.5 g) after granulation, bottled, capped and labeled.
服用方法同实施例1,该产品除具有抗衰老、抗紫外辐射、增强免疫功能外,同时具有促进脑细胞的生长发育,改善大脑机能,用于中枢神经疾病的预防和治疗,使视神经活性化,强化视力等功能,无毒副作用。The method of administration is the same as that in Example 1. In addition to anti-aging, anti-ultraviolet radiation, and enhanced immune function, this product can also promote the growth and development of brain cells, improve brain function, and be used for the prevention and treatment of central nervous diseases and activate the optic nerve. , Enhance vision and other functions, no toxic side effects.
实施例11、以生产1000粒片剂为例Embodiment 11, taking the production of 1000 tablets as an example
将适量淀粉或糊精、1.0克维生素C、1.5克酵母抽提物混匀,加入银杏叶抽提液100克和虾青素2克混匀,制粒后烘干,整粒后压片(每片重0.5克),装瓶封盖贴标即可。Mix an appropriate amount of starch or dextrin, 1.0 g of vitamin C, and 1.5 g of yeast extract, add 100 g of ginkgo biloba extract and 2 g of astaxanthin, mix evenly, dry the granules, and compress the granules ( Each tablet weighs 0.5 grams), bottled, sealed and labeled.
服用方法同实施例1,该产品除具有抗衰老、抗紫外辐射、增强免疫功能、预防白内障等生理功能外,同时还具有促进脑血液循环,改善大脑机能,降低血脂等功能,无毒副作用。The administration method is the same as in Example 1. In addition to the physiological functions of anti-aging, anti-ultraviolet radiation, enhancing immune function, and preventing cataracts, the product also has the functions of promoting cerebral blood circulation, improving brain function, and reducing blood lipids. It has no toxic and side effects.
实施例12、以生产1000粒片剂为例Embodiment 12, taking the production of 1000 tablets as an example
将适量淀粉或糊精、1.0克维生素C、1.5克酵母抽提物混匀,加入绿藻精抽提液100克和虾青素2克混匀,制粒后烘干,整粒后压片(每片重0.5克),装瓶封盖贴标即可。Mix an appropriate amount of starch or dextrin, 1.0 g of vitamin C, and 1.5 g of yeast extract, add 100 g of chlorella extract and 2 g of astaxanthin, mix well, granulate, dry, and tablet after granulation (Each tablet weighs 0.5 grams), bottled, capped and labeled.
服用方法同实施例1,该产品除具有抗衰老、抗紫外辐射和预防白内障等生理功能外,同时还具有更强的增强免疫功能的作用,无毒副作用。The administration method is the same as that in Example 1. In addition to the physiological functions of anti-aging, anti-ultraviolet radiation and cataract prevention, the product also has a stronger effect of enhancing immune function and has no toxic and side effects.
实施例13、以生产1000粒片剂为例Embodiment 13, taking the production of 1000 tablets as an example
将适量淀粉或糊精、1.0克维生素C、1.5克酵母抽提物混匀,加入番茄红素抽提液100克和虾青素2克混匀,制粒后烘干,整粒后压片(每片重0.5克),装瓶封盖贴标即可。Mix an appropriate amount of starch or dextrin, 1.0 g of vitamin C, and 1.5 g of yeast extract, add 100 g of lycopene extract and 2 g of astaxanthin, mix evenly, granulate, dry, and tablet after granulation (Each tablet weighs 0.5 grams), bottled, capped and labeled.
服用方法同实施例1,该产品中添加番茄红素,可以充分发挥虾青素的抗氧化活性,具有更好的抗衰老、抗紫外辐射、增强免疫功能、预防白内障等生理功能,无毒副作用。The method of administration is the same as that in Example 1. Adding lycopene to this product can give full play to the antioxidant activity of astaxanthin, and has better anti-aging, anti-ultraviolet radiation, enhanced immune function, cataract prevention and other physiological functions, without toxic and side effects .
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101001549A CN1324989C (en) | 2005-10-10 | 2005-10-10 | Nutrition food containing astaxanthin and its preparing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101001549A CN1324989C (en) | 2005-10-10 | 2005-10-10 | Nutrition food containing astaxanthin and its preparing method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1748573A true CN1748573A (en) | 2006-03-22 |
CN1324989C CN1324989C (en) | 2007-07-11 |
Family
ID=36604374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101001549A Active CN1324989C (en) | 2005-10-10 | 2005-10-10 | Nutrition food containing astaxanthin and its preparing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1324989C (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102228176A (en) * | 2011-05-19 | 2011-11-02 | 北京康比特体育科技股份有限公司 | Composition for increasing immunity and its preparation method |
CN102960520A (en) * | 2012-11-29 | 2013-03-13 | 山东福田科技集团有限公司 | L-arabinose health-care press candy added with cyclocarya paliurus |
CN103815223A (en) * | 2014-01-23 | 2014-05-28 | 山东百龙创园生物科技有限公司 | Nutrition health-care composition containing astaxanthin |
CN105879015A (en) * | 2014-10-23 | 2016-08-24 | 大连世纪新源技术开发有限公司 | Deuterium depleted water (DDW) oral liquid capable of preventing cancer and aging |
WO2019196374A1 (en) * | 2018-04-11 | 2019-10-17 | 华南理工大学 | Astaxanthin-containing condiment and preparation method therefor |
CN112544968A (en) * | 2020-12-04 | 2021-03-26 | 正当年医药科技(广州)有限公司 | Whitening and freckle removing composition and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE522246C2 (en) * | 1997-02-27 | 2004-01-27 | Astacarotene Ab | Oral preparation for prophylactic and therapeutic treatment of Helicobacter Sp. infection |
JP2001002569A (en) * | 1999-06-18 | 2001-01-09 | Itano Refrigerated Food Co Ltd | Composition for improving memory |
CN1181209C (en) * | 2003-02-24 | 2004-12-22 | 天津大学 | Method for producing astaxanthin by mixed culture and fermentation of astaxanthin-producing algae and yeast |
CN1225546C (en) * | 2003-07-23 | 2005-11-02 | 天津大学 | Method for preparing astaxanthin from alga cultivated by using residue of fermenting yeast |
-
2005
- 2005-10-10 CN CNB2005101001549A patent/CN1324989C/en active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102228176A (en) * | 2011-05-19 | 2011-11-02 | 北京康比特体育科技股份有限公司 | Composition for increasing immunity and its preparation method |
CN102960520A (en) * | 2012-11-29 | 2013-03-13 | 山东福田科技集团有限公司 | L-arabinose health-care press candy added with cyclocarya paliurus |
CN103815223A (en) * | 2014-01-23 | 2014-05-28 | 山东百龙创园生物科技有限公司 | Nutrition health-care composition containing astaxanthin |
CN105879015A (en) * | 2014-10-23 | 2016-08-24 | 大连世纪新源技术开发有限公司 | Deuterium depleted water (DDW) oral liquid capable of preventing cancer and aging |
WO2019196374A1 (en) * | 2018-04-11 | 2019-10-17 | 华南理工大学 | Astaxanthin-containing condiment and preparation method therefor |
US12048317B2 (en) | 2018-04-11 | 2024-07-30 | South China University Of Technology | Astaxanthin-containing condiment and a preparation method therefor |
CN112544968A (en) * | 2020-12-04 | 2021-03-26 | 正当年医药科技(广州)有限公司 | Whitening and freckle removing composition and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1324989C (en) | 2007-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1425452A (en) | Longan aril and wolfberry fruit polysaccharide health-care liquid and its preparing method and use | |
CN104839688A (en) | Eye care preparation and preparation method thereof | |
CN1522144A (en) | Compositions for preventing human cancer and method of preventing human cancer | |
US20160151437A1 (en) | Nutritional supplements for improved vision and methods of treating the same | |
US20210177912A1 (en) | Non-winterized, standardized marine source oil products and methods of making thereof | |
CN1194703C (en) | Health-care food for protecting gastric mucosa and its preparing process | |
CN106213505A (en) | A kind of Moringa Haematocoocus Pluvialls tabletting health product and preparation method thereof | |
CN1748573A (en) | Nutritious food containing astaxanthin and its preparation method | |
KR20160144388A (en) | Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin | |
CN110506879A (en) | A kind of solid beverage and its preparation method for alleviating visual fatigue | |
WO2015163316A1 (en) | Composition for preventing or improving peripheral neuropathy | |
CN107788526A (en) | A kind of nutriment for protecting Bones and joints | |
RU2332030C1 (en) | Food product of prophylactic purpose | |
CN1258994C (en) | Fruit vinegar chewing tablet food and its preparation method | |
CN1436490A (en) | Production process of natural marine organism health food with deep sea clam worm as material | |
RU2492867C1 (en) | Biologically active additive | |
CN111567805A (en) | Water-soluble haematococcus pluvialis astaxanthin soft capsule and preparation method thereof | |
JP2023113905A (en) | Composition and nutritional supplement made therefrom | |
CN1915337A (en) | Capsule of eye protector for patient of diabetes | |
CN113519846A (en) | Fish oil extract multi-algae tablet capable of reducing blood fat and enhancing fat metabolism in vivo and preparation method thereof | |
CN1423961A (en) | Chitin healthy food and production thereof | |
CN112675295A (en) | Blueberry powder compound solid preparation capable of preventing and improving osteoarthritis and preparation method and application thereof | |
KR20160134787A (en) | Composition and method to alleviate joint pain using phospholipids and astaxanthin | |
US20080194517A1 (en) | Equine or canine immunomodulating composition and treatment method | |
CN100500199C (en) | Salmon roe nutrition and health-care soft capsule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SOUTH LEE KUM KEE CO., LTD. Free format text: FORMER OWNER: SOUTH CHINA UNIVERSITY OF TECHNOLOGY Effective date: 20080905 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080905 Address after: Guangdong Province, Guangzhou Tianhe Software Park Construction Road No. 66 Capitol business building 4 layer tower Patentee after: Nanfang Lee Kum Kee Co., Ltd. Address before: No. five, 381 mountain road, Guangzhou, Guangdong, Tianhe District Patentee before: South China University of Technology |
|
C56 | Change in the name or address of the patentee |
Owner name: WUJIXIAN (CHINA) CO., LTD. Free format text: FORMER NAME: SOUTHERN CO. LIJINJI CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Guangdong Province, Guangzhou Tianhe Software Park Construction Road No. 66 Capitol business building 4 layer tower Patentee after: Unlimited (China) Limited Address before: Guangdong Province, Guangzhou Tianhe Software Park Construction Road No. 66 Capitol business building 4 layer tower Patentee before: Nanfang Lee Kum Kee Co., Ltd. |